Anton P. Porsteinsson
Director of the University of Rochester Alzheimer's Disease Care, Research and Education Program · University of Rochester
Credentials: · · · ·
History
PresentResearch and Education Program · University of Rochester
- 1987–1989
University of Iceland
- 1987
University of Iceland School of Medicine
Research
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease
New England Journal of Medicine · 2014 · 1,518 citations
Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders
Systematic review or meta-analysis · Biological Psychiatry · 2010 · 546 citations
Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021
Case report · The Journal of Prevention of Alzheimer s Disease · 2021 · First of 5 authors · 492 citations
46 papers
42 papers
- CL
34 papers
- LS
32 papers
19 papers
18 papers
18 papers
- CD
17 papers
Grants
- 2016–2024
Escitalopram for Agitation in Alzheimer Disease
National Institute on Aging · R01
PI · $16.8M · Johns Hopkins University
- 2003–2009
Depression in Alzheimer's Disease Study 2 (DIADS-2)
National Institute of Mental Health · U01
Contact PI · $317.4K · University of Rochester
Clinical trials
- 2009–2013
Citalopram for Agitation in Alzheimer's Disease
Principal investigator · Completed · Phase 3
JHSPH Center for Clinical Trials